BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38224873)

  • 21. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.
    Uribe P; Wistuba II; González S
    Am J Dermatopathol; 2003 Oct; 25(5):365-70. PubMed ID: 14501284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
    Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
    Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in melanocytic nevi treated with laser hair removal: A systematic review.
    Cices A; Dover JS; Labadie JG
    Lasers Surg Med; 2023 Sep; 55(7):617-624. PubMed ID: 37493510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TERT promoter mutation is uncommon in acral lentiginous melanoma.
    Liau JY; Tsai JH; Jeng YM; Chu CY; Kuo KT; Liang CW
    J Cutan Pathol; 2014 Jun; 41(6):504-8. PubMed ID: 24588324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms.
    Lee S; Barnhill RL; Dummer R; Dalton J; Wu J; Pappo A; Bahrami A
    Sci Rep; 2015 Jun; 5():11200. PubMed ID: 26061100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genomic landscape of childhood and adolescent melanoma.
    Lu C; Zhang J; Nagahawatte P; Easton J; Lee S; Liu Z; Ding L; Wyczalkowski MA; Valentine M; Navid F; Mulder H; Tatevossian RG; Dalton J; Davenport J; Yin Z; Edmonson M; Rusch M; Wu G; Li Y; Parker M; Hedlund E; Shurtleff S; Raimondi S; Bhavin V; Donald Y; Mardis ER; Wilson RK; Evans WE; Ellison DW; Pounds S; Dyer M; Downing JR; Pappo A; Bahrami A
    J Invest Dermatol; 2015 Mar; 135(3):816-823. PubMed ID: 25268584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
    Chen PL; Chen WS; Li J; Lind AC; Lu D
    Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
    Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
    Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
    Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
    Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
    Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.
    Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R
    JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thermographic examination of cutaneous melanocytic nevi].
    Mikulska D
    Ann Acad Med Stetin; 2009; 55(1):31-8; discussion 38. PubMed ID: 20349589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic mimics of malignant melanoma.
    Bsirini C; Smoller BR
    Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.